DVA - DaVita HealthCare Partners Market Cap to Sales Volume

Symbol and logo of brand DaVita Inc (DVA)

DaVita Inc. (DVA) dominance in the dialysis segment and stringent regulatory standards create insurmountable barriers to entry for new players, ensuring stable demand. Fluctuations in the P/S multiple clearly demonstrate the business valuation dynamics, while the 0.80 indicator reflects the status of the current value. The company's financial foundation relies on the operation of a global network of specialized centers for patients with kidney failure.

Market Cap to Revenue: davita.com (DVA) for 07/04/2022 - 11/15/2026

Metric breakdowns and analytics for DaVita (DVA)

- price and consensus price forecast:
Market Chart DaVita Inc|DVA - Consensus Target
- market capitalization statistics:
Market Value DaVita Corp|DVA - Enterprise Value
- book capitalization information:
Book Value per Share DaVita|DVA - Company Net Assets|Market Value to Book Value davita.com|DVA - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient DaVita Inc.|DVA - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio DaVita Inc.|DVA - Company Aggregate Debts|Debt to Book Value DaVita Inc.|DVA - Company Long-Term Liabilities|Short-Term Debt Volume DaVita|Immediate Liquidity Ratio davita.com
- company profitability and valuation multiples indicators:
DVA - Net Income|Expected Profit DaVita Inc.|DVA - P/E Multiple|Forward P/E Multiple DaVita Inc.|DVA - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio DaVita|DVA - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year DaVita|DVA - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months davita.com|DVA - Earnings growth in current year|Earnings growth forecast for next year DaVita Inc.
- sales revenue and business income indicators:
DVA - Company Sales|Company Projected Revenue Volume DaVita HealthCare Partners|DVA - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple DaVita Corp
General company analysis:DVA (DaVita Inc)
Core merchandise of davita.com

To protect capital from market volatility, it is essential for an investor to determine the fair value of the business via the price-to-sales ratio. The stable influx of patients into the DaVita Inc. (DVA) dialysis center ecosystem confirms revenue resilience, allowing for the use of the price-to-sales multiple to analyze the premium paid for every dollar of revenue under strict Medicare tariff regulations.

Who DaVita Inc. competes with

HCA (HCA Healthcare) - Market Capitalization-to-Revenue Ratio|Tenet Healthcare Corporation - Market Cap to Revenue|Fresenius Medical (FMS) - Price to Sales|Solventum Corp - P/S Multiple|Price-to-Sales Ratio EHC|Universal Health Services (UHS) - Price-to-Revenue Ratio|RDNT: Market Cap to Sales Volume|Market Cap to Revenue OPCH|Price to Sales Surgery Partners, Inc. SGRY|Market Cap to Revenue PINC (Premier, Inc.)|EYE (National Vision) - Market Capitalization-to-Revenue Ratio|P/S Multiple PGNY (Progyny Inc)|Ardent Health Partners (ARDT) - Price to Sales|Select Medical Inc. - P/S Multiple|Price to Sales Apollo Medical Holdings|MD: P/S Multiple|Market Cap to Revenue US Physical Therapy|Market Cap to Revenue PNTG|Organogenesis Holdings Inc. (ORGO) - Price-to-Revenue Coefficient|Market Cap to Revenue NUTX (Nutex Health Corp)|AUNA (Auna Health) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio sbc-holdings.com SBC|evolus.com - Price-to-Revenue Ratio|Community Health Systems, Inc. - P/S Multiple|SKIN: Price-to-Revenue Ratio|MDWD: P/S Multiple|BTMD: Market Cap to Sales Volume|Market Cap to Revenue JYNT|Price to Sales DocGo Inc. DCGO|PIII (P3 Health Partners, Inc.) - Price-to-Revenue Coefficient|GANX (Gain Therapeutics) - Market Capitalization-to-Revenue Ratio|P/S Multiple EUDA (EUDA Health Holdings)|BMGL (Basel Medical Group Limited) - Price-to-Sales Ratio|CLGN - Price-to-Revenue Ratio|Price to Sales cuprina.com.sg|CCM: P/S Multiple|AMS: Market Cap to Sales Volume|MRM (MEDIROM Corp) - P/S Multiple|ALBT: Market Capitalization-to-Revenue Ratio|P/S Multiple DHAI|Longevity Health Holdings - Market Cap to Revenue Ratio|Price-to-Revenue Ratio NewGenIvf Group Ltd NIVF|ATIP (atipt.com) - Price-to-Sales Ratio|CMAX: Market Cap to Revenue|Price to Sales Kindly Health|ModivCare (MODV) - Price-to-Revenue Ratio|NVOS (novointegrated.com) - Price-to-Revenue Ratio|SSY (SunLink Health Systems Inc.) - P/S Multiple|BACK (IMAC Holdings Inc) - Market Cap to Sales Volume